FDA Approves Abaloparatide (Tymlos) for Osteoporosis in Men

The FDA has approved abaloparatide (Tymlos) for increasing bone density in men with osteoporosis at high risk for fracture.
FDA Approvals

source https://www.medscape.com/viewarticle/986014?src=rss